Global Plasmid DNA CDMO Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Plasmid DNA CDMO Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Plasmid DNA CDMO report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Plasmid DNA CDMO market is projected to reach US$ 664 million in 2029, increasing from US$ 168.9 million in 2022, with the CAGR of 22.0% during the period of 2024 to 2029. Demand from DNA Vaccines and Gene Therapy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Plasmid DNA CDMO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Plasmid DNA CDMO key companies include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics and Cobra Biologics, etc. GenScript ProBio, Biovian, Biomay are top 3 players and held % share in total in 2022.
Plasmid DNA CDMO can be divided into GMP Grade Plasmid DNA and Non-GMP Grade Plasmid DNA, etc. GMP Grade Plasmid DNA is the mainstream product in the market, accounting for % share globally in 2022.
Plasmid DNA CDMO is widely used in various fields, such as DNA Vaccines, Gene Therapy, Immunotherapy and Others, etc. DNA Vaccines provides greatest supports to the Plasmid DNA CDMO industry development. In 2022, global % share of Plasmid DNA CDMO went into DNA Vaccines filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Plasmid DNA CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
GenScript ProBio
Biovian
Biomay
VGXI
Esco Aster
Catalent
Richter-Helm BioLogics
Cytovance Biologics
Cobra Biologics
Obiosh
Thermo Fisher
Aldevron(Danaher)
Charles River Laboratories
WuXi AppTec
AGC Biologics
AcuraBio
GENE Chem
Eurogentec
PlasmidFactory
Segment by Type
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Plasmid DNA CDMO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Plasmid DNA CDMO introduction, etc. Plasmid DNA CDMO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Plasmid DNA CDMO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Plasmid DNA CDMO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Plasmid DNA CDMO key companies include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics and Cobra Biologics, etc. GenScript ProBio, Biovian, Biomay are top 3 players and held % share in total in 2022.
Plasmid DNA CDMO can be divided into GMP Grade Plasmid DNA and Non-GMP Grade Plasmid DNA, etc. GMP Grade Plasmid DNA is the mainstream product in the market, accounting for % share globally in 2022.
Plasmid DNA CDMO is widely used in various fields, such as DNA Vaccines, Gene Therapy, Immunotherapy and Others, etc. DNA Vaccines provides greatest supports to the Plasmid DNA CDMO industry development. In 2022, global % share of Plasmid DNA CDMO went into DNA Vaccines filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Plasmid DNA CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
GenScript ProBio
Biovian
Biomay
VGXI
Esco Aster
Catalent
Richter-Helm BioLogics
Cytovance Biologics
Cobra Biologics
Obiosh
Thermo Fisher
Aldevron(Danaher)
Charles River Laboratories
WuXi AppTec
AGC Biologics
AcuraBio
GENE Chem
Eurogentec
PlasmidFactory
Segment by Type
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
Segment by Application
DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Plasmid DNA CDMO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Plasmid DNA CDMO introduction, etc. Plasmid DNA CDMO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Plasmid DNA CDMO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices